Company Active LTD

Company profile

Iota Sciences Limited

UK company 10246957, incorporated on 23 June 2016.

Home - IOTA Sciences

Iota Sciences Limited is a UK company with status Active founded in 2016 based in South East England.

Company number

10246957

Incorporated

23 Jun 2016

Companies House status

Active

Company identity

Founded / incorporated

23 June 2016

Company number 10246957

Verify at Companies House

Legal name

IOTA SCIENCES LIMITED

Company type

Private Limited Company

Region

South East England

Registered address

BEGBROKE SCIENCE PARK BEGBROKE HILL

WOODSTOCK ROAD

YARNTON

OXFORDSHIRE

OX5 1PF

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller

Company Active LTD

Iota Sciences Limited

CRN 10246957

Direct and ultimate controller Active PLC

Oxford Science Enterprises PLC

CRN 09093331

Latest accounts

Financial period: 1 Jul 2024 to 31 Dec 2024

FULLACCOUNTS

Turnover

Unknown

Profit / Loss

-£651,657

Employees

Company events

Reference milestones and recent Companies House filing stream events.

7 events

30 Sep

2027

Accounts due

Accounts Due

Next accounts due date

06 Jul

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jul

2026

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzUzNjAwNjcwMmFkaXF6a2N4

Published 30 Jul 2026 09:55

07 Jul

2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUzMDA3Njg2M2FkaXF6a2N4 | Paper/PDF filed

Published 08 Jul 2026 22:59

22 Jun

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec

2025

Accounts filed

Accounts

Last accounts made up date

23 Jun

2016

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2026

Funded years

2026

Age at first award

9 years

Projects

2026 Innovation Loans Lead participant

Building a universal single-cell handling platform through automated Artificial Intelligence cell recognition

3 Feb 2026 to 3 Nov 2027

Awarded

£1,041,199

Total cost £1,041,199

The rapid growth of gene editing and single-cell Omics for therapeutic development such as Cell and Gene Therapies (CGT) and other applications has led to significant expansion in R&D and commercial laboratories and an associated demand to improve related workflow efficiencies, in particular single-cell handling solutions enabling genetically homogenous c...

Product types

Innovation Loans